Literature DB >> 9854100

Definition of false-positive reactions in screening for hepatitis C virus antibodies.

M Schröter1, H H Feucht, P Schäfer, B Zöllner, S Polywka, R Laufs.   

Abstract

The rate of false-positive hepatitis C virus enzyme immunoassay results was determined to be at least 10% among 1,814 reactive serum samples based on (i) negative results in an independent confirmation assay, (ii) negative PCR results, and (iii) no patients developing clinical or biochemical signs of hepatitis during a 1-year follow-up.

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 9854100      PMCID： PMC84219     

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  17 in total

1.  Transmission of hepatitis C virus by organ transplantation.

Authors:  B J Pereira; E L Milford; R L Kirkman; A S Levey
Journal:  N Engl J Med       Date:  1991-08-15       Impact factor: 91.245

2.  Improved detection of hepatitis C virus antibodies in high-risk populations.

Authors:  J G McHutchison; J L Person; S Govindarajan; B Valinluck; T Gore; S R Lee; M Nelles; A Polito; D Chien; R DiNello
Journal:  Hepatology       Date:  1992-01       Impact factor: 17.425

3.  Antibody response to core, envelope and nonstructural hepatitis C virus antigens: comparison of immunocompetent and immunosuppressed patients.

Authors:  A S Lok; D Chien; Q L Choo; T M Chan; E K Chiu; I K Cheng; M Houghton; G Kuo
Journal:  Hepatology       Date:  1993-09       Impact factor: 17.425

4.  Confirmation of hepatitis C virus antibody in blood donors.

Authors:  B C Dow; I Coote; H Munro; F McOmish; P L Yap; P Simmonds; E A Follett
Journal:  J Med Virol       Date:  1993-11       Impact factor: 2.327

5.  Analysis of ELISA hepatitis C virus-positive blood donors population by polymerase chain reaction and recombinant immunoblot assay (RIBA). Comparison of second and third generation RIBA.

Authors:  C Chicheportiche; J F Cantaloube; P Biagini; P Aumont; F Donnadieu; J Escher; F Larabi; J P Zepitelli
Journal:  Acta Virol       Date:  1993 Apr-Jun       Impact factor: 1.162

6.  Confirmation of hepatitis C virus infection by new four-antigen recombinant immunoblot assay.

Authors:  C L Van der Poel; H T Cuypers; H W Reesink; A J Weiner; S Quan; R Di Nello; J J Van Boven; I Winkel; D Mulder-Folkerts; P J Exel-Oehlers
Journal:  Lancet       Date:  1991-02-09       Impact factor: 79.321

7.  Recombinant immunoblot assay reaction patterns and hepatitis C virus RNA in blood donors and non-A, non-B hepatitis patients.

Authors:  D Bresters; H L Zaaijer; H T Cuypers; H W Reesink; I N Winkel; P J van Exel-Oehlers; A A van Drimmelen; P L Jansen; C L van der Poel; P N Lelie
Journal:  Transfusion       Date:  1993-08       Impact factor: 3.157

8.  Patterns of serological markers in transfusion-transmitted hepatitis C virus infection using second-generation HCV assays.

Authors:  P N Lelie; H T Cuypers; H W Reesink; C L van der Poel; I Winkel; E Bakker; P J van Exel-Oehlers; D Vallari; J P Allain; L Mimms
Journal:  J Med Virol       Date:  1992-07       Impact factor: 2.327

9.  Use of aminotransferase, hepatitis C antibody, and hepatitis C polymerase chain reaction RNA assays to establish the diagnosis of hepatitis C virus infection in a diagnostic virology laboratory.

Authors:  D Gretch; W Lee; L Corey
Journal:  J Clin Microbiol       Date:  1992-08       Impact factor: 5.948

10.  Evaluation of indeterminate c22-3 reactivity in volunteer blood donors.

Authors:  L H Tobler; M P Busch; J Wilber; R Dinello; S Quan; A Polito; R Kochesky; C Bahl; M Nelles; S R Lee
Journal:  Transfusion       Date:  1994-02       Impact factor: 3.157
View more
  8 in total

1.  Case-reporting of acute hepatitis B and C among injection drug users.

Authors:  Holly Hagan; Nadine Snyder; Eileen Hough; Tianji Yu; Shelly McKeirnan; Janice Boase; Jeffrey Duchin
Journal:  J Urban Health       Date:  2002-12       Impact factor: 3.671

2.  Diagnostic reliability of Architect anti-HCV assay: Experience of a tertiary care hospital in India.

Authors:  Gnanadurai John Fletcher; Anantharam Raghavendran; Jayashree Sivakumar; Prasanna Samuel; Priya Abraham
Journal:  J Clin Lab Anal       Date:  2017-06-28       Impact factor: 2.352

3.  Comparison of a newly developed automated and quantitative hepatitis C virus (HCV) core antigen test with the HCV RNA assay for clinical usefulness in confirming anti-HCV results.

Authors:  Recep Kesli; Hakki Polat; Yuksel Terzi; Muhammet Guzel Kurtoglu; Yavuz Uyar
Journal:  J Clin Microbiol       Date:  2011-09-21       Impact factor: 5.948

4.  Diagnostic accuracy of blood centers in the screening of blood donors for viral markers.

Authors:  Elliot Eli Dogbe; Fareed Arthur
Journal:  Pan Afr Med J       Date:  2015-02-10

5.  Heterologous Immunity between Adenoviruses and Hepatitis C Virus (HCV): Recombinant Adenovirus Vaccine Vectors Containing Antigens from Unrelated Pathogens Induce Cross-Reactive Immunity Against HCV Antigens.

Authors:  Babita Agrawal; Nancy Gupta; Satish Vedi; Shakti Singh; Wen Li; Saurabh Garg; Jie Li; Rakesh Kumar
Journal:  Cells       Date:  2019-05-26       Impact factor: 6.600

6.  Detection of Influenza Virus Using a SOI-Nanoribbon Chip, Based on an N-Type Field-Effect Transistor.

Authors:  Kristina A Malsagova; Tatyana O Pleshakova; Andrey F Kozlov; Rafael A Galiullin; Vladimir P Popov; Fedor V Tikhonenko; Alexander V Glukhov; Vadim S Ziborov; Ivan D Shumov; Oleg F Petrov; Vladimir M Generalov; Anastasia A Cheremiskina; Alexander G Durumanov; Alexander P Agafonov; Elena V Gavrilova; Rinat A Maksyutov; Alexander S Safatov; Valentin G Nikitaev; Alexander N Pronichev; Vladimir A Konev; Alexander I Archakov; Yuri D Ivanov
Journal:  Biosensors (Basel)       Date:  2021-04-12

7.  Improving Diagnosis of Hepatitis C Virus Infection Using Hepatitis C Core Antigen Testing in a Resource-Poor Setting.

Authors:  Ayswarya Kannan; Lalitha Biswas; Anil Kumar; Jessy Kurian; Anjaly S Nair; Parasmal Suresh; Shine Sadasivan; Raja Biswas
Journal:  Rev Soc Bras Med Trop       Date:  2021-02-10       Impact factor: 1.581

8.  Relevance of reactivity in commercially available hepatitis C virus antibody assays.

Authors:  S Polywka; M Schröter; H H Feucht; B Zöllner; R Laufs
Journal:  J Clin Microbiol       Date:  2001-04       Impact factor: 5.948
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.